[Experience with sulbactam/cefoperazone in the field of obstetrics and gynecology]. 1984

T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida

Sulbactam/cefoperazone (SBT/CPZ) was studied for clinical efficacy in the field of obstetrics and gynecology, and following results were obtained: In the treatment of 6 cases of gynecological infection, the clinical efficacy of SBT/CPZ was assessed as excellent in 1 case and effective in 5 cases. Neither adverse effects nor abnormalities in laboratory findings due to SBT/CPZ were observed. Based on these results, SBT/CPZ is considered to be a highly effective antibiotic with clinical efficacy in obstetric and gynecological infections in the daily dosage of 2 g given in two divided doses.

UI MeSH Term Description Entries
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
October 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
October 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
October 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
November 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
November 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
December 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
November 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
November 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
November 1984, The Japanese journal of antibiotics,
T Kohara, and Y Matsui, and M Noda, and S Hirai, and S Iida
November 1984, The Japanese journal of antibiotics,
Copied contents to your clipboard!